This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Vanderbilt University School of Medicine (VSOM) and the American Association for Cancer Research (AACR). VSOM is accredited by ACCME to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
VSOM designates this educational activity for a maximum of 30.5 AMA PRA Category 1 Credit
™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
Cancer prevention research and practices are continually evolving. It is critical that the most up-to-date research reaches the bedside, and this is accomplished through the education of the physicians who have daily interactions with the patients. Some general recommendations may be made to patients as they pertain to nutrition, obesity, and physical activity, but more detailed knowledge is needed for physicians to accurately assess patient risk and determine appropriate early detection screening or prophylactic treatment options. This conference will bring together experts from all areas of prevention research to address topics such as the latest advancements in predicting cancer risk, imaging pre-malignant disease, and preventing cancer related to chronic infections. Sessions will aim to review some of the controversies in cancer prevention, such as those that surround use of SERMS and aromatase inhibitors in breast cancer patients or approaches for smoking cessation. The education disseminated during this conference may be taken back to offices and clinics and immediately applied to daily practice.
This trans-disciplinary, international conference is presented for basic, translational, clinical, epidemiological, and behavioral scientists, and physician-scientists involved in cancer prevention research and all subdisciplines of biomedical science related to cancer prevention research.
After participating in this CME activity, physicians should be able to:
- Formulate treatment plans with vaccines and anti-infectives for the prevention of infection-related cancers.
- Critically assess the results of clinical trials of preventive drugs to better explain the risk-benefit issues and challenges encountered in their use.
- Explain the key factors that contribute to cancer risk (such as heredity, racial/ethnic disparities, obesity, nutrition, and metabolism); the currently available screening and prevention options that are appropriate for risk level; and assist patients in making informed life-style changes and treatment decisions.
- Articulate tobacco-control science and public policy and utilize them in cancer prevention research and practice.
It is the policy of VSOM that the information presented at VSOM-sponsored CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, VSOM and the AACR will provide information that Committee members and speakers have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. This disclosure information is available in the Program/Proceedings
of this conference.
CLAIMING CME CREDIT
The deadline for the submission of requests for credit for CME has elapsed. Please contact the AACR Office of CME at firstname.lastname@example.org
or (215) 440-9300 with further inquiries.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
Supporters of this activity are listed in the Final Program.